Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
357.7 USD | +0.36% | +1.44% | +19.47% |
25.04. | Cigna bietet Humira-Rivalen mit $0 Zuzahlung in Spezialapotheke an | RE |
24.04. | The Cigna Group beschließt Quartalsdividende, zahlbar am 20. Juni 2024 | CI |
ETFs investiert in Cigna
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
2,33% | 8 M€ | +2.44% | ||
2,28% | 18 M€ | +4.21% | - | |
1,93% | 2 M€ | +6.77% | ||
1,81% | 1 M€ | +2.21% | - | |
1,09% | 204 M€ | +10.54% | ||
1,05% | 9 M€ | -.--% | - | |
0,95% | 5 M€ | -72.95% | - | |
0,92% | 1 M€ | +16.32% | ||
0,88% | 3 M€ | +15.16% | - | |
0,88% | 4 M€ | -.--% | - | |
0,88% | 13 M€ | -.--% | - | |
0,70% | 10 M€ | +6.26% | ||
0,68% | 4 592 M€ | +11.18% | ||
0,61% | 3 859 M€ | +18.82% | - | |
0,61% | 469 M€ | -2.05% | - | |
0,61% | 717 M€ | +5.83% | ||
0,55% | 8 M€ | +3.30% | - | |
0,48% | 52 M€ | +6.60% | ||
0,48% | 5 M€ | -.--% | - | |
0,46% | 219 M€ | +17.17% | - | |
0,46% | 1 448 M€ | -.--% | - | |
0,44% | 26 M€ | +2.32% | - | |
0,43% | 330 M€ | -.--% | - | |
0,40% | 2 M€ | +14.69% | - | |
0,40% | 2 510 M€ | +11.01% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+19.47% | 101 Mrd. | |
-7.84% | 450 Mrd. | |
+12.69% | 124 Mrd. | |
-0.93% | 39.4 Mrd. | |
-33.36% | 36.53 Mrd. | |
-5.34% | 20.15 Mrd. | |
-13.07% | 3.13 Mrd. | |
-40.07% | 969 Mio. | |
-31.71% | 334 Mio. |
- Börse
- Aktien
- A2PA9L Aktie
- ETFs Cigna